Literature DB >> 31069704

A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia.

Babafunso Aderemi Adenuga1, Timothy William Rennie2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31069704     DOI： 10.1007/s40264-019-00832-3

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  4 in total

1.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

2.  Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

Authors:  Carrie E Pierce; Sieta T de Vries; Stephanie Bodin-Parssinen; Linda Härmark; Phil Tregunno; David J Lewis; Simon Maskell; Raphael Van Eemeren; Alicia Ptaszynska-Neophytou; Victoria Newbould; Nabarun Dasgupta; Antoni F Z Wisniewski; Sara Gama; Peter G M Mol
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

3.  Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.

Authors:  Rebecca Zash; Joseph Makhema; Roger L Shapiro
Journal:  N Engl J Med       Date:  2018-07-24       Impact factor: 91.245

4.  Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.

Authors:  Dorina Onoya; Kamban Hirasen; Liudmyla van den Berg; Jacqui Miot; Lawrence C Long; Matthew P Fox
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.